RE:RE:RE:RE:RE:RE:Cmon Mat!(not Brad).....let’s see a nice positive update!Folks, I guarantee you that management and the BOD know exactly what is going on in the industry regarding past, current and future possible compounds that may or may not become SOC. Conversely no one on this or any board knows what other products are pending as possible "direct" competition for the exact indications Pela is targeted at.
I understand in the absence of news and with little communication from the company - most likely due to ongoung negotiations around PANCAN, with the FDA, and possibly BD deals - its easy to fabricate scenarios. But until something concrete is delivered by way of a NR, EVERYTHING on here is pure speculation.
I await the repercussions of this post... ;)